Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Roundhill NVDA WeeklyPay ETF (NVDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Roundhill NVDA WeeklyPay ETF — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.22 (market cap $1.74B), while Roundhill NVDA WeeklyPay ETF trades at $37.8 (market cap $119.10M). The key difference: Nuvation Bio Inc. Class A Common Stock is far larger — about 14.6× Roundhill NVDA WeeklyPay ETF's market cap, and Roundhill NVDA WeeklyPay ETF is more actively traded (44,838 versus 9,289,619). Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Roundhill NVDA WeeklyPay ETF for 50 Days on average.
| NUVB | NVDW | |
|---|---|---|
Market Cap | $1.74B | $119.10M |
Volume | 9,289,619 | 44,838 |
Sector | Health | Income / Options Overlay |
52-Week High | $9.54 | $52.33 |
52-Week Low | $3.41 | $31.88 |
Typical Hold Time | 0 Days | 50 Days |
Enterprise Value | $1.33B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Roundhill NVDA WeeklyPay ETF
NVDW is an actively managed ETF that seeks to provide weekly distributions and returns equal to 1.2 times (120%) the calendar week performance of Nvidia (NVDA) common shares. It combines modest leverage with a high-frequency payout schedule, designed for investors who want amplified exposure to Nvidia alongside a consistent weekly income stream.
Read more on NVDW →
